Safety, reactogenicity, and immunogenicity of a 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in healthy adult pregnant women: study protocol for a phase 3 open-label randomized controlled trial
暂无分享,去创建一个
E. Karita | S. Allen | S. Nsanzimana | K. Wall | F. Priddy | F. Sayinzoga | A. Tichacek | R. Parker | T. Sharkey | J. Nyombayire | R. Ingabire | J. Mukamuyango | Amelia Mazzei | D. Anumendem | M. Schaefer | M. Katwere | Cynthia Robinson | M. Leyssen | C. Robinson | Maarten Leyssen | Michael Katwere